Original language | English |
---|---|
Journal | Multiple Sclerosis and Related Disorders |
Volume | 41 |
DOIs | |
Publication status | Published - 2020 |
Which is the best PML risk stratification strategy in natalizumab-treated patients affected by multiple sclerosis?
C. Prezioso, M.A. Zingaropoli, M. Iannetta, D.M. Rodio, M. Altieri, A. Conte, V. Vullo, M.R. Ciardi, A.T. Palamara, V. Pietropaolo
Research output: Contribution to journal › Article › peer-review